Come up with a name for your new list and we'll add to it:
Affigen raised a round of funding on February 21, 2017. Investors include
Black Beret Life Sciences.
Affigen is a biotechnology company that develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers.…